Selection of macrophage-resistant progressor tumor variants by the normal host requirement for concomitant T cell-mediated immunity

Journal of Experimental Medicine

Volumn 157, Issue 2, 1983, Pages 642-656

  Urban, James L ^a   Schreiber, Hans ^a  

^a University of Chicago ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOISOTOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; CANCER GROWTH; CELLULAR IMMUNITY; CHROMIUM 51 RELEASE; CYTOTOXICITY; FIBROSARCOMA; IN VITRO STUDY; MACROPHAGE; MOUSE; T LYMPHOCYTE;

ANIMAL; ANTIGENS, NEOPLASM; CELL TRANSFORMATION, NEOPLASTIC; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FEMALE; FIBROSARCOMA; IMMUNITY, CELLULAR; MACROPHAGE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0020664188     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.157.2.642     Document Type: Article

References (35)

1. Nowell, P. C. 1976. The clonal evolution of tumor cell populations. Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression. Science (Wash. DC). 194: 23.
2. Urban, J. L., R. C. Burton, J. M. Holland, M. L. Kripke, and H. Schreiber. 1982. Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells. J. Exp. Med. 155: 557.
3. Hibbs, J. B., Jr., L. H. Lambert, Jr., and J. S. Remington. 1972. Control of carcinogenesis: a possible role for the activated macrophage. Science (Wash. DC). 177: 998.
4. Adams, D. O., and R. Snyderman. 1979. Do macrophages destroy nascent tumors? J. Nat. Cancer Inst. 62: 1341.
5. Urban, J. L. 1981. Macrophage-induced enhancement of endogenous tumor lysosome activity. Cancer Res. 41: 2221.
6. Meltzer, M. S. 1981. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation. J. Immunol. 127: 179.
7. Glasebrook, A. L., and F. W. Fitch. 1980. Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J. Exp. Med. 151: 876.
8. Kripke, M. L. 1977. Latency, histology and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. Cancer Res. 37: 1395.
9. Fisher, M. S., and M. L. Kripke. 1977. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Proc. Natl. Acad. Sci. USA. 74: 1688.
10. Flood, P. M., M. L. Kripke, D. A. Rowley, and H. Schreiber. 1980. Suppression of tumor rejection by autologous anti-idiotypic immunity. Proc. Natl. Acad. Sci. USA. 77: 2209.
11. Oldham, R. K., J. R. Ortaldo, H. T. Holden, and R. B. Herberman. 1977. Cytotoxicity inhibition assay: cryopreservation and standardization. J. Natl. Cancer Inst. 59: 1321.
12. Burton, R. C, and H.J. Winn. 1981. Studies on natural killer (NK) cells. I. NK cell specific antibodies in CE anti-CBA serum. J. Immunol. 126: 1985.
13. Meltzer, M. S. 1976. Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice. Cell. Immunol. 22: 176.
14. Roder, J. C, M. L. Lohmann-Matthes, W. Domzig, R. Kiessling, and O. Haller. 1979. A functional comparison of tumor cell killing by activated macrophages and natural killer cells. Eur. J. Immunol. 9: 283.
15. Tucker, R. W., M. S. Meltzer, and K. K. Sanford. 1981. Susceptibility to killing by BCG-activated macrophages associated with "spontaneous" neoplastic transformation in culture. Int. J. Cancer 27: 555.
16. Currie, G. A. 1978. Activated macrophages kill tumor cells by releasing arginase. Nature (Land.). 273: 758.
17. Tonkonogy, S. L., and H. J. Winn. 1976. A new alloantigen system associated with the mis locus in the mouse. J. Immunol. 116: 835.
18. Gray, J. D., C. G. Brooks, and R. W. Baldwin. 1981. Detection of either rapidly cytolytic macrophages or NK cells in "activated" peritoneal exudates depends on the method of analysis and the target cell type. Immunology. 42: 561.
19. Fidler, I. J., R. O. Roblin, and G. Poste. 1978. In vitro tumoricidal activity of macrophages against virus-transformed lines with temperature-dependent transformed phenotypic characteristics. Cell. Immunol. 38: 131.
20. Wortzel, R. D., J. L. Urban, C. Philipps, and H. Schreiber. 1982. Dissection of a tumor-specific transplantation antigen using variant tumor clones selected by T cell lines in vitro. Fed. Proc. 41: 726.
21. Marino, P. A., C. C. Whisnart, and D. O. Adams. 1981. Binding of bacillus Calmette-Guérin-activated macrophages to tumor targets. Selective inhibition by membrane preparations from homologous and heterologous neoplastic cells. J. Exp. Med. 154: 77.
22. Adams, D. O., and P. A. Marino. 1981. Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor. J. Immunol. 126: 981.
23. Hamilton, T. A., and M. Fishman. 1981. Characterization of the recognition of target cells sensitive or resistant to cytolysis by activated rat peritoneal macrophages. J. Immunol. 127: 1702.
24. Nathan, C. F., B. A. Arrick, H. W. Murray, N. M. DeSantis, and Z. A. Cohn. 1980. Tumor cell anti oxidant defenses: inhibition of the glutathione redox cycle enhances macrophage -mediated cytolysis. J. Exp. Med. 153: 766.
25. Pace, J. L., and S. W. Russell. 1981. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide. J. Immunol. 126: 1863.
26. Mackaness, G. B. 1969. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J. Exp. Med. 129: 973.
27. Nathan, C. F., M. L. Karnovsky, and J. R. David. 1971. Alterations of macrophage functions by mediators from lymphocytes. J. Exp. Med. 133: 1356.
28. Berendt, M. J., R. J. North, and D. P. Kirstein. 1978. The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunity. J. Exp. Med. 148: 1560.
29. Loveland, B. E., and I. F. C McKenzie. 1982. Which T cells cause graft rejection. Transplantation (Baltimore). 33: 217.
30. Russell, S. W., and G. Y. Gillespie. 1977. Nature, function and distribution of inflammatory cells in regressing and progrssing Moloney sarcomas. J. Reticuloendolhel. Soc. 22: 159.
31. Talmadge, J. E., M. Key, and I. J. Fidler. 1981. Macrophage content of metastatic and nonmetastatic rodent neoplasms. J. Immunol. 126: 2245.
32. Lill, P. H., and G. W. Fortner. 1978. Identification and cytotoxic reactivity of inflammatory cells recovered from progressing or regressing syngeneic UV-induced murine tumors. J. Immunol. 121: 1854.
33. Urban, J. L., J. M. Holland, M. L. Kripke, and H. Schreiber. 1982. Immunoselection of tumor cell variants by mice suppressed with ultraviolet radiation. J. Exp. Med. 156: 1025.
34. Mantovani, A. 1981. In vitro effects on tumor cells of macrophages isolated from an early-passage chemically-induced murine sarcoma and from its spontaneous metastases. Int. J. Cancer. 27: 221.
35. Flood, P. M., J. L. Urban, M. L. Kripke, and H. Schreiber. 1981. Loss of tumor-specific and idiotype-specific immunity with age. J. Exp. Med. 154: 275.